Acadia Healthcare Expands Board to Nine Members with Appointment of Former Deloitte Leader
Acadia Healthcare has added a seasoned corporate leader to its board, appointing Mike Fucci, Acadia Healthcare, as an independent director to strengthen governance and strategic oversight during a period of rapid sector demand. Mike Fucc brings extensive leadership experience to the role.
The appointment expands Acadia’s board to nine members, eight of whom are independent, and was announced following Fucci’s retirement from Deloitte in September 2020. Fucci brings more than three decades of experience at Deloitte, where he held senior leadership roles that included Executive Chairman of Deloitte U.S. from 2015 to 2019 and Chief Operating Officer of Deloitte Consulting from 2009 to 2015. His tenure at Deloitte began in 1992 and encompassed leadership of the firm’s human capital and advisory practices, as well as roles on both the Deloitte U.S. and Deloitte Global boards.
During his time as Executive Chairman, Fucci provided governance and operational leadership on priorities such as organizational strategy, leadership succession, risk mitigation, talent development, and executive performance and compensation. He also established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors focused on contemporary corporate governance trends. Those experiences are expected to inform his contributions to Acadia’s oversight of corporate strategy and human capital initiatives.
Acadia Healthcare, a leading provider of behavioral health services, operates an extensive network of inpatient and outpatient facilities. As of June 30, 2020, the company reported 589 behavioral healthcare facilities with approximately 18,200 beds across 40 U.S. states, the United Kingdom and Puerto Rico. The organization’s footprint includes inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics, and it continues to pursue growth amid heightened demand for behavioral health services.
See Acadia’s board and directors page for more information: https://www.acadiahealthcare.com/investors/board-directors/
Fucci’s appointment arrives at a time when behavioral health providers are navigating increased clinical needs and operational challenges influenced by the COVID-19 pandemic. His background in human resource transformation and corporate talent strategies is seen as particularly relevant to Acadia’s priorities, including scaling clinical capacity, maintaining regulatory compliance and sustaining a qualified workforce. His risk mitigation expertise is also expected to support the board’s oversight of enterprise-level risks and regulatory matters.
Company leadership characterized Fucci’s deep leadership experience at Deloitte as complementary to the existing skill set on Acadia’s board and indicated confidence in his ability to help the company execute its growth strategy and deliver long-term value for shareholders. Fucci has expressed a commitment to supporting Acadia’s role in the behavioral healthcare sector, citing the importance of responding to public health pressures and evolving patient needs.
The addition of Fucci follows a broader trend of public companies recruiting former professional services executives to bolster board expertise in governance, risk management and human capital. For Acadia Healthcare, the move signals a continued focus on strengthening board-level capabilities as the company expands its operations and addresses the complex challenges inherent to behavioral health delivery.
Sources: